Clin Cancer Res – 2019 Nov 15 – PMID: 31358542

Saksham Arorapublications
Dagogo-Jack I, Rooney MM, Lin JJ, Nagy RJ, Yeap BY, Hubbeling H, Chin E, Ackil J, Farago AF, Hata AN, Lennerz JK, Gainor JF, Lanman RB, Shaw AT. Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity. Clin Cancer Res. 2019 Nov 15;25(22):6662-6670. PMID: 31358542